BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2138710)

  • 1. [Recurrent post-infectious immune complex glomerulonephritis with persistent activation of the alternative complement pathway].
    Arslan-Kirchner M; Ehrich JH; Kirschfink M; Helmchen U; Brodehl J
    Monatsschr Kinderheilkd; 1990 Feb; 138(2):81-4. PubMed ID: 2138710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles and acute glomerulonephritis.
    Lin CY; Hsu HC
    Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of complement components in disease.
    Luskin AT; Tobin MC
    Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential complement changes after childhood acute nephritis.
    Hammond N; Dawson KP
    N Z Med J; 1979 Jul; 90(640):55-7. PubMed ID: 290899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute post-streptococcal glomerulonephritis associated with prolonged hypocomplementaemia.
    Payne D; Houtman P; Browning M
    J Clin Pathol; 2008 Oct; 61(10):1133-5. PubMed ID: 18820103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
    Hisano S; Matsushita M; Fujita T; Takeshita M; Iwasaki H
    Pathol Int; 2007 Jun; 57(6):351-7. PubMed ID: 17539966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K; Ward D; Ruddy S
    Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple immunofixation test for induced C3 degradation in disease states (including C3 nephritic factor) and its correlation with kidney biopsy.
    Sarkar E; Roberts EG; Wallage MJ; Unsworth DJ; Lock RJ
    J Immunol Methods; 2014 Jan; 402(1-2):71-5. PubMed ID: 24239583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternate complement pathway. A possible role in a patient with focal glomerular sclerosis.
    Stapleton FB; Linshaw MA; Cuppage FE; Kim YK; Quie PG
    Arch Pathol Lab Med; 1981 Mar; 105(3):160-3. PubMed ID: 6894082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between anti-glycolipid antibodies and alternative complement pathway in pediatric renal glomerular diseases].
    Mimura A; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):943-53. PubMed ID: 3266645
    [No Abstract]   [Full Text] [Related]  

  • 17. Serial studies of circulating immune complexes in poststreptococcal glomerulonephritis.
    Lin CY
    Pediatrics; 1982 Nov; 70(5):725-7. PubMed ID: 7133824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Berger's disease. Study of eleven cases (author's transl)].
    García García L; Giménez Llort A; Camacho Díaz JA; Cusí Sánchez MV; López Cacho F
    An Esp Pediatr; 1982 Mar; 16(3):210-8. PubMed ID: 6980613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum complement activation pathways and circulating anti-streptolysin-0 antibodies: diagnostic value in glomerulonephritis in children].
    Rabhi H; Ghaffor M; Salah-Salah H; Abbadi MC
    Arch Inst Pasteur Alger; 1986; 55():99-105. PubMed ID: 2978952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.